Evidence map›Paper›PMID 30581874›Full record

ArticleJournal of immunology research2018

Investigation of Outbreak-Specific Nonsynonymous Mutations on Ebolavirus GP in the Context of Known Immune Reactivity.

Kerrie Vaughan, Xiaojun Xu, Bjoern Peters, Alessandro Sette

Abstract read
In one paragraph

Article in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kerrie VaughanLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.ORCID 0000-0002-3528-4731
Xiaojun XuLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Bjoern PetersLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Alessandro SetteLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.ORCID 0000-0001-7013-2250

Funding

NIAID NIH HHS HHSN272201200010C
6 · The paper itself

Abstract

The global response to the most recent EBOV outbreak has led to increased generation and availability of data, which can be globally analyzed to increase our understanding of immune responses to EBOV. We analyzed the published antibody epitope data to identify regions immunogenic for humans on the main GP antigenic target and determine sequence variance/nonsynonymous mutations between historical isolates and variants from the 2013-2016 outbreak. Approximately half of the GP sequence has been reported as targeted by antibody responses. Our results show an enrichment of nonsynonymous mutations (NSMs) within epitopic regions on GP (70%,

Indexed as

Antibodies, NeutralizingAntibodies, ViralAntigenic VariationDisease OutbreaksEbola VaccinesEbolavirusEpitope MappingEpitopes, B-LymphocyteHemorrhagic Fever, EbolaHumansImmunity, HumoralImmunotherapyMutationUnited StatesViral Envelope ProteinsAntibodies, NeutralizingAntibodies, ViralEbola Vaccinesenvelope glycoprotein, Ebola virusEpitopes, B-LymphocyteViral Envelope Proteins

Identifiers

PMID30581874
PMCPMC6276448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.